FDA Indications: An alternative drug for treatment-resistant depression (not considered a first-line drug of choice) FDA approved for treating major depression mixed anxiety and depression and phobic or hypochondriacal features FDA approved for treating atypical depression (e.g
There is also the circumstance when someone has another diagnosis, such as Lyme disease, but treatments have been ineffective in resolving symptoms
Customizable dosing to meet individual patient needs.
People have looked at DEPLETING glutathione as a possible treatment for cancers
Quality assurance procedures include peptide identity confirmation, analytical purity verification, copper complex integrity testing, formulation consistency evaluation, packaging inspection, microbial quality testing where appropriate, and batch-specific quality control documentation
New genes tied to endocrine, metabolic, and dietary regulation of lifespan from a Caenorhabditis elegans genomic RNAi screen